Icon (ICLR) Competitors $183.49 -4.22 (-2.25%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$185.90 +2.41 (+1.31%) As of 10/10/2025 07:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ICLR vs. MEDP, CRL, IQV, TMO, TCOM, WCN, RDDT, GRAB, AER, and GIBShould you be buying Icon stock or one of its competitors? The main competitors of Icon include Medpace (MEDP), Charles River Laboratories International (CRL), IQVIA (IQV), Thermo Fisher Scientific (TMO), Trip.com Group (TCOM), Waste Connections (WCN), Reddit (RDDT), Grab (GRAB), Aercap (AER), and CGI Group (GIB). Icon vs. Its Competitors Medpace Charles River Laboratories International IQVIA Thermo Fisher Scientific Trip.com Group Waste Connections Reddit Grab Aercap CGI Group Medpace (NASDAQ:MEDP) and Icon (NASDAQ:ICLR) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, media sentiment, risk, profitability, analyst recommendations and dividends. Is MEDP or ICLR more profitable? Medpace has a net margin of 18.74% compared to Icon's net margin of 9.82%. Medpace's return on equity of 67.66% beat Icon's return on equity.Company Net Margins Return on Equity Return on Assets Medpace18.74% 67.66% 21.86% Icon 9.82%10.95%6.23% Do analysts rate MEDP or ICLR? Medpace presently has a consensus target price of $422.27, suggesting a potential downside of 15.75%. Icon has a consensus target price of $217.33, suggesting a potential upside of 18.44%. Given Icon's stronger consensus rating and higher possible upside, analysts clearly believe Icon is more favorable than Medpace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medpace 3 Sell rating(s) 12 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.00Icon 0 Sell rating(s) 9 Hold rating(s) 9 Buy rating(s) 2 Strong Buy rating(s) 2.65 Which has more volatility & risk, MEDP or ICLR? Medpace has a beta of 1.4, indicating that its stock price is 40% more volatile than the S&P 500. Comparatively, Icon has a beta of 1.23, indicating that its stock price is 23% more volatile than the S&P 500. Does the media prefer MEDP or ICLR? In the previous week, Medpace had 4 more articles in the media than Icon. MarketBeat recorded 19 mentions for Medpace and 15 mentions for Icon. Icon's average media sentiment score of 0.83 beat Medpace's score of 0.76 indicating that Icon is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medpace 7 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Icon 8 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals hold more shares of MEDP or ICLR? 78.0% of Medpace shares are owned by institutional investors. Comparatively, 95.6% of Icon shares are owned by institutional investors. 20.3% of Medpace shares are owned by company insiders. Comparatively, 44.0% of Icon shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has stronger valuation & earnings, MEDP or ICLR? Icon has higher revenue and earnings than Medpace. Icon is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedpace$2.11B6.68$404.39M$13.4537.27Icon$8.28B1.79$791.47M$9.7218.88 SummaryIcon beats Medpace on 9 of the 17 factors compared between the two stocks. Get Icon News Delivered to You Automatically Sign up to receive the latest news and ratings for ICLR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ICLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ICLR vs. The Competition Export to ExcelMetricIconMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.82B$8.09B$6.04B$10.28BDividend YieldN/A2.16%5.68%4.78%P/E Ratio18.8854.5964.4822.86Price / Sales1.7939.30613.94131.69Price / Cash9.1521.7025.7330.17Price / Book1.566.7612.756.52Net Income$791.47M$247.60M$3.31B$276.31M7 Day Performance-5.36%-4.12%0.79%-0.88%1 Month Performance4.85%-2.79%6.67%3.48%1 Year Performance-38.15%7.73%77.62%30.15% Icon Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ICLRIcon3.888 of 5 stars$183.49-2.2%$217.33+18.4%-38.1%$14.82B$8.28B18.8841,900Analyst ForecastAnalyst RevisionMEDPMedpace4.2008 of 5 stars$530.30-0.4%$422.27-20.4%+44.1%$14.96B$2.23B39.435,900Trending NewsAnalyst ForecastAnalyst RevisionCRLCharles River Laboratories International4.1998 of 5 stars$175.02-1.3%$179.93+2.8%-13.4%$8.73B$4.05B-131.5920,100Analyst DowngradeIQVIQVIA4.885 of 5 stars$205.10-0.7%$230.32+12.3%-13.5%$35.13B$15.41B29.6888,000Trending NewsAnalyst ForecastAnalyst RevisionTMOThermo Fisher Scientific4.8994 of 5 stars$544.44+0.2%$585.37+7.5%-12.1%$205.16B$42.88B31.49125,000Positive NewsAnalyst ForecastTCOMTrip.com Group4.5984 of 5 stars$71.39-2.6%$76.98+7.8%+7.8%$47.90B$7.30B19.5641,073Positive NewsAnalyst ForecastGap UpWCNWaste Connections4.9254 of 5 stars$174.15-0.2%$213.79+22.8%-4.9%$44.75B$8.92B70.2223,854News CoverageAnalyst ForecastRDDTReddit2.8007 of 5 stars$203.61-1.7%$201.58-1.0%+171.4%$38.78B$1.30B185.102,233Trending NewsAnalyst ForecastInsider TradeGRABGrab1.7441 of 5 stars$6.39+3.7%$5.90-7.7%+60.5%$24.81B$2.80B159.7911,267Analyst ForecastAERAercap2.5814 of 5 stars$125.13-0.3%$122.57-2.0%+28.2%$23.44B$7.98B7.78740News CoverageAnalyst ForecastGIBCGI Group3.6999 of 5 stars$91.13-0.6%$148.25+62.7%-23.0%$20.43B$10.79B16.8490,250Analyst Forecast Related Companies and Tools Related Companies MEDP Alternatives CRL Alternatives IQV Alternatives TMO Alternatives TCOM Alternatives WCN Alternatives RDDT Alternatives GRAB Alternatives AER Alternatives GIB Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ICLR) was last updated on 10/12/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredRobinhood warningA strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Icon Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Icon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
